CPe-III(CPe-III-S)

General Information


DRACP ID  DRACP01098

Peptide Name   CPe-III(CPe-III-S)

Sequence  RQSHFANAQP

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Chickpea (Cicer arietinum L.)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma EC50=2.38 μmol/mL MTT assay 72h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma EC50=1.50 μmol/mL MTT assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  p53 protein

Affinity  Not available

Mechanism  the bioactive peptide combined the DNA binding domain of p53 protein by hydrogen bonds, induced the expression of p53 protein and facilitated its stability so that it inhibited the cell proliferation.

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01098

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C49H74N18O15

Absent amino acids  CDEGIKLMTVWY

Common amino acids  AQ

Mass  131595

Pl  10.55

Basic residues  2

Acidic residues  0

Hydrophobic residues  3

Net charge  2

Boman Index  -3410

Hydrophobicity  -142

Aliphatic Index  20

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Antioxidant activity and anti-proliferative effect of a bioactive peptide from chickpea (Cicer arietinum L.)

Doi 10.1016/j.foodres.2015.09.027

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.